品牌现货直购
供应商:我要出现这里


查看所有供应商和价格请点击:

85466-18-8生产厂家

85466-18-8价格

85466-18-8

85466-18-8结构式
85466-18-8结构式
  • 常用中文名:查摸丁卡
  • 常用英文名:Thymopoietin II: 32-35
  • CAS号:85466-18-8
  • 分子式:C21H40N8O7
  • 分子量:516.59200
  • 相关类别: 研究领域 炎症/免疫
  • 发布时间:2018-03-20 08:00:00
  • 更新时间:2024-01-02 12:55:55
  • 胸腺生成素(胸腺生成素II(32-35))是胸腺因子(胸腺生成肽)的32-35片段。Thymocartin已显示出在免疫缺陷疾病研究中的潜力[1][2]。

化源商城直购

中文名 查摸丁卡
英文名 (2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid
中文别名 GLY-GLU-GLN-ARG-LYS-ASP-VAL-TYR-VAL-GLN-LEU-TYR-LEU: GENRKDVYVQLYL
胸腺卡汀
英文别名 Rgh 0206
Thymocartina [INN-Spanish]
Thymocartine [INN-French]
Thymocartinum [INN-Latin]
Thymocartina
Thymocartin
Thymopoietin II: 32-35
密度 1.45g/cm3
分子式 C21H40N8O7
分子量 516.59200
精确质量 516.30200
PSA 275.84000
LogP 1.13990
折射率 1.619

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV9384000
CHEMICAL NAME :
L-Valine, N-(N-(N(sup 2)-L-arginyl-L-lysyl)-L-alpha-aspartyl)-
CAS REGISTRY NUMBER :
85466-18-8
LAST UPDATED :
199410
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C21-H40-N8-O7
MOLECULAR WEIGHT :
516.69

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 11,764,1986